NEUP

4.22

3.65% -0.16

Handel nachbörslich: 4.27 0.05 +1.18%

Neuphoria Therapeutics Inc (NEUP)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$4.38

Offen:

$4.25

24-Stunden-Volumen:

118.17K

Relative Volume:

0.08

Marktkapitalisierung:

$7.93M

Einnahmen:

$15.66M

Nettoeinkommen (Verlust:

$5.83M

KGV:

-0.1766

EPS:

-23.8939

Netto-Cashflow:

$466.20K

1W Leistung:

-10.40%

1M Leistung:

-78.31%

6M Leistung:

-16.52%

1J Leistung:

+0.00%

1-Tages-Spanne:

$4.15

$4.41

1-Wochen-Bereich:

$4.15

$4.91

52-Wochen-Spanne:

$2.90

$21.40

Neuphoria Therapeutics Inc Stock (NEUP) Company Profile

Firmenname

Neuphoria Therapeutics Inc

Sektor

Healthcare (1135)

Branche

Biotechnology (633)

Telefon

781-439-5551

Adresse

100 SUMMIT DR, BURLINGTON

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

NEUP's Discussions on Twitter

Vergleichen Sie NEUP mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NEUP Neuphoria Therapeutics Inc	4.22	10.33M	15.66M	5.83M	466.20K	-23.89
VRTX Vertex Pharmaceuticals Inc	421.67	109.22B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	628.00	67.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	423.47	57.35B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	831.48	50.87B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	182.77	39.72B	447.02M	-1.18B	-868.57M	-6.1812

Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-09-28	Hochstufung	H.C. Wainwright	Neutral → Buy
2023-09-28	Bestätigt	Maxim Group	Buy
2022-01-10	Eingeleitet	Berenberg	Buy
2022-01-10	Eingeleitet	Cantor Fitzgerald	Overweight
2022-01-10	Eingeleitet	Evercore ISI	Outperform
2022-01-10	Eingeleitet	H.C. Wainwright	Buy

Alle ansehen

Neuphoria Therapeutics Inc Aktie (NEUP) Neueste Nachrichten

06:10 AM

Is Neuphoria Therapeutics Inc. stock attractive after correctionRate Cut & Fast Exit and Entry Trade Guides - newser.com

06:10 AM

03:33 AM

Can Neuphoria Therapeutics Inc. stock maintain operating marginsJuly 2025 EndofMonth & Safe Capital Growth Tips - newser.com

03:33 AM

01:59 AM

Will Neuphoria Therapeutics Inc. stock attract more institutional investorsEarnings Trend Report & Stepwise Trade Execution Plans - newser.com

01:59 AM

Nov 03, 2025

What indicators show strength in Neuphoria Therapeutics Inc.2025 AllTime Highs & Consistent Return Strategy Ideas - newser.com

Nov 03, 2025

Can Neuphoria Therapeutics Inc. stock hit analyst price targets2025 Volatility Report & AI Driven Stock Movement Reports - newser.com

Nov 03, 2025

What valuation multiples suggest for Neuphoria Therapeutics Inc. stockJuly 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com

Nov 03, 2025

How to read the order book for Neuphoria Therapeutics Inc.July 2025 Gainers & Weekly High Conviction Trade Ideas - newser.com

Nov 03, 2025

What does recent volatility data suggest for Neuphoria Therapeutics Inc.2025 Investor Takeaways & AI Driven Price Forecasts - newser.com

Nov 03, 2025

What Wall Street predicts for Neuphoria Therapeutics Inc. stock priceJuly 2025 Decliners & Breakout Confirmation Alerts - newser.com

Nov 03, 2025

Why hedge funds are buying Neuphoria Therapeutics Inc. stockQuarterly Trade Review & Risk Controlled Daily Plans - newser.com

Nov 03, 2025

Will Neuphoria Therapeutics Inc. stock deliver shareholder valueTrade Entry Report & Fast Entry High Yield Stock Tips - newser.com

Nov 03, 2025

Nov 02, 2025

Can Neuphoria Therapeutics Inc. stock rebound after recent weaknessJuly 2025 Weekly Recap & Community Supported Trade Ideas - newser.com

Nov 02, 2025

How Neuphoria Therapeutics Inc. stock performs in interest rate cyclesJuly 2025 Earnings & Fast Moving Stock Watchlists - newser.com

Nov 02, 2025

Will Neuphoria Therapeutics Inc. stock keep outperforming rivalsEntry Point & Free AI Powered Buy and Sell Recommendations - newser.com

Nov 02, 2025

Neuphoria Therapeutics Inc.’s volatility index tracking explainedWeekly Profit Analysis & Low Risk Profit Maximizing Plans - newser.com

Nov 02, 2025

Can Neuphoria Therapeutics Inc. stock sustain institutional interestStop Loss & Verified Short-Term Trading Plans - newser.com

Nov 02, 2025

Nov 01, 2025

Why analysts upgrade Neuphoria Therapeutics Inc. stockShare Buyback & Stock Portfolio Risk Management - newser.com

Nov 01, 2025

Using AI based signals to follow Neuphoria Therapeutics Inc.July 2025 Decliners & Low Risk High Reward Ideas - newser.com

Nov 01, 2025

Is Neuphoria Therapeutics Inc. showing signs of accumulationQuarterly Earnings Report & Expert Approved Momentum Trade Ideas - newser.com

Nov 01, 2025

Oct 31, 2025